Compare Aurora Cannabis Inc (ACB) vs AXT Inc (AXTI) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Aurora Cannabis Inc vs AXT Inc — how do they compare? Aurora Cannabis Inc trades at $2.67 (market cap $165.36M), while AXT Inc trades at $60.1 (market cap $3.80B). The key difference: AXT Inc is far larger — about 23× Aurora Cannabis Inc's market cap, and AXT Inc is trading nearer its 52-week high, Aurora Cannabis Inc nearer its low. Which is the better fit depends on your goals.
| ACB | AXTI | |
|---|---|---|
Market Cap | $165.36M | $3.80B |
Sector | Health | Technology |
52-Week High | $6.23 | $140.83 |
52-Week Low | $2.67 | $1.92 |
Enterprise Value | $99.82M | $3.77B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aurora Cannabis (ACB) trades at $2.71, down 4.58% on the day, with a bearish technical outlook. The company reported a net income of $1.59 million in 2025, a significant improvement from a $69 million loss in 2024, though 2026 guidance projects a net loss of $136 million. Revenue grew to $343.29 million in 2025, but faces headwinds from Canadian reimbursement pressures. Analyst consensus is mixed, with 21.43% buy, 57.14% hold, and 21.43% sell ratings.
The stock's low P/B of 0.47 suggests undervaluation, but negative profitability metrics and a projected reset year in 2027 pose risks. Investment appeal hinges on execution in high-margin international medical markets, though volatility and competitive pressures remain key concerns for shareholders.
AXTI trades at $63.52, up 12.19% today, but remains in a bearish technical trend with support at $60 and resistance at $64. The company reported a net loss of $21.26M in 2025 despite revenue of $88.33M, though 2026 projections show improving margins. Recent news highlights strong AI-driven demand for indium phosphide and a record $100M backlog, with earnings scheduled for July 30, 2026.
Outlook is mixed: analyst consensus is bullish (64% buy ratings) based on AI growth potential, but profitability challenges and geopolitical risks in China pose significant headwinds. The stock's high P/S ratio of 30.7 suggests premium valuation despite current losses, making execution critical for upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Aurora Cannabis Inc
Aurora Cannabis, based in Edmonton, Canada, grows and distributes both medical and recreational cannabis under several brands, including Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. While its main market is Canada, the company has also expanded globally through medical cannabis export agreements.
Read more on ACB →About AXT Inc
AXT develops and manufactures high-performance compound semiconductor wafer substrates. Its products, like indium phosphide and gallium arsenide, are essential for data centers, 5G, and consumer electronics.
Read more on AXTI →
